CBIH Cannabis Bioscience International Holdings, Inc.

Fundamentals / CIK 0001411057 / USD

Cannabis Bioscience International Holdings, Inc. reported $124K in revenue and a net loss of $515K for the trailing twelve months ended February 28, 2026 (down 25.0% year over year), with a 78.8% gross margin and a -322.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CBIH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$421K$211K$0-$992KFY 2023 Revenue: $317KFY 2023 Net Income: -$1.03M2023FY 2024 Revenue: $249KFY 2024 Net Income: -$651K2024FY 2025 Revenue: $303KFY 2025 Net Income: -$549K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement May 31 May 31 May 31
Revenue $303K $249K $317K
Cost of Revenue $40K $46K $93K
Gross Profit $263K $203K $223K
Total Operating Expenses $684K $689K $1.21M
Operating Income -$421K -$486K -$983K
Interest Expense $136K $154K $91K
Income Tax Expense -- $0 $0
Net Income -$549K -$651K -$1.03M
Basic EPS -$0.00 -$0.00 -$0.00
Diluted EPS -$0.00 -$0.00 -$0.00
Basic Shares Outstanding 10.72B 10.32B 9.00B
Diluted Shares Outstanding 10.72B 10.32B 9.00B

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Revenue $11K $53K $24K $35K $15K $74K $179K $76K
Cost of Revenue $3.0K $10K $8.1K $4.5K $19K $7.8K $8.4K $9.9K
Gross Profit $8.2K $43K $16K $30K -$4.5K $66K $171K $66K
Total Operating Expenses $101K $139K $91K $165K $125K $126K $268K $96K
Operating Income -$93K -$96K -$75K -$135K -$129K -$60K -$98K -$30K
Interest Expense $11K $18K $17K $103K $22K $8.7K $2.3K --
Net Income -$104K -$117K -$83K -$212K -$181K -$80K -$76K -$136K
Basic EPS -$0.00 -$0.00 -$0.00 -- -$0.00 -$0.00 -$0.00 --
Diluted EPS -$0.00 -$0.00 -$0.00 -- -$0.00 -$0.00 -$0.00 --
Basic Shares Outstanding 11.63B 11.63B 11.63B -- 10.73B 10.50B 10.46B --
Diluted Shares Outstanding 11.63B 11.63B 11.63B -- 10.73B 10.50B 10.46B --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet May 31 May 31 May 31
Accounts Receivable, Net $6.4K $20K $10.0K
Other Current Assets $598 $598 $598
Total Current Assets $29K $21K $19K
Total Non-Current Assets $2.8K $36K $24K
Total Assets $32K $57K $43K
Short-Term Debt $15K $7.1K $15K
Deferred Revenue (Current) -- $0 $29K
Total Current Liabilities $946K $882K $386K
Long-Term Debt $250K $249K $250K
Total Non-Current Liabilities $250K $254K $250K
Total Liabilities $1.20M $1.14M $635K
Total Debt (incl. Leases) $269K $283K $269K
Common Stock $0 $0 $0
Retained Earnings -$5.88M -$5.33M -$4.68M
Total Stockholders' Equity -$1.16M -$1.08M -$592K
Total Equity -$1.16M -$1.08M -$592K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2024-08-31 2024-05-31 2024-02-29 2023-11-30
Accounts Receivable, Net $1.3K $22K $9.0K $6.4K $17K $20K $17K $19K
Other Current Assets $188 $188 $598 $598 $598 $598 $598 --
Total Current Assets $1.5K $22K $19K $29K $19K $21K $18K $20K
Total Non-Current Assets $0 $0 $0 $2.8K $28K $36K $76K $82K
Total Assets $1.5K $22K $19K $32K $46K $57K $94K $102K
Short-Term Debt $15K $15K $15K $15K $7.1K $7.1K $7.1K $12K
Deferred Revenue (Current) -- -- -- -- -- $0 $0 $0
Total Current Liabilities $1.22M $1.14M $1.02M $946K $852K $882K $801K $660K
Long-Term Debt $250K $250K $250K $250K $250K $249K $250K $250K
Total Non-Current Liabilities $250K $250K $250K $250K $250K $254K $269K $283K
Total Liabilities $1.47M $1.39M $1.27M $1.20M $1.10M $1.14M $1.07M $944K
Total Debt (incl. Leases) $264K $264K $264K $269K $279K $283K $332K $266K
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$6.19M -$6.08M -$5.97M -$5.88M -$5.41M -$5.33M -$5.20M -$5.20M
Total Stockholders' Equity -$1.47M -$1.36M -$1.25M -$1.16M -$1.06M -$1.08M -$976K -$842K
Total Equity -$1.47M -$1.36M -$1.25M -$1.16M -$1.06M -$1.08M -$976K -$842K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement May 31 May 31 May 31
Net Income -$549K -$651K -$1.03M
Stock-Based Compensation -- $0 $12K
Change in Receivables $14K -$10K -$4.9K
Operating Cash Flow -$330K -$479K -$898K
Common Stock Issued $244K $70K $802K
Financing Cash Flow $342K $471K $875K
Net Change in Cash $12K -$8.2K -$23K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Net Income -$104K -$117K -$83K -$212K -$181K -$80K -$76K -$136K
Change in Receivables $21K -$13K -$2.6K -$3.7K $11K $3.4K $3.0K -$3.1K
Operating Cash Flow -$15K -$5.5K -$104K -$144K -$83K -$72K -$30K -$174K
Common Stock Issued -- -- $0 -- -- -- $0 -$5.0K
Financing Cash Flow -- -- -- $157K -- -- $31K $174K
Net Change in Cash -$42 -$91 -$13K $12K -$454 $33 $214 --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth May 31 May 31 May 31
Gross Margin 86.8% 81.7% 70.5%
Operating Margin -139.1% -195.4% -310.4%
Net Profit Margin -181.1% -261.8% -325.9%
Return on Assets (ROA) -1721.5% -1139.5% -2380.2%
Current Ratio 0.03x 0.02x 0.05x
Revenue Growth (YoY) +21.8% -21.5% --
Gross Profit Growth (YoY) +29.4% -9.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Gross Margin 78.8% 66.6% 73.1% 86.8% 86.8% 89.6% 87.3% 81.7%
Operating Margin -322.6% -341.4% -268.7% -139.1% -91.9% -94.9% -107.6% -185.2%
Net Profit Margin -416.8% -465.3% -374.3% -181.1% -137.5% -137.1% -153.8% -261.7%
Return on Assets (ROA) -33373.6% -2677.7% -2930.8% -1721.5% -- -- -1179.5% -1139.5%
Current Ratio 0.00x 0.02x 0.02x 0.03x -- -- 0.02x 0.02x
Revenue Growth (YoY) -25.0% -28.3% -86.5% -53.9% -59.0% +16.5% +145.7% --
Gross Profit Growth (YoY) -- -35.6% -90.6% -53.9% -118.1% +36.6% +166.4% --
Source: SEC EDGAR CompanyFacts (CIK 0001411057) · from November 30, 2010 Data through February 28, 2026 · synced Nov 21, 2026, 05:12 UTC · Open in terminal